tiprankstipranks
GT Biopharma sees cash runway into 2H24
The Fly

GT Biopharma sees cash runway into 2H24

The Company had cash, cash equivalents and short-term investments of $16.01 million as of September 30, 2023 compared to $17.97 million as of June 30, 2023. We expect ample runway to fund operations into 2H 2024.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles